Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRC-CHKVLP059-00-VP vaccine in healthy adults
NCT02562482Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2015
- Primary completion
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 2 trial of CHIKV VLP vaccine in chikungunya virus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2015; status: completed.
02
Drugs
CHIKV VLP vaccine
03
Conditions
chikungunya virus infection
Beyond the preview
Go deeper on NCT02562482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562482.